Posttransplant hyperamylasemia is associated with decreased patient and graft survival in pancreas allograft recipients.
Cheng
S S
SS
Mayo Clinic, Rochester, Minnesota.
Munn
S R
SR
D000328:Adult; D000681:Amylases / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000401:mortality / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D008297:Male; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000401:mortality / Q000502:physiology*; D011379:Prognosis; D015996:Survival Rate; D013997:Time Factors; D014184:Transplantation, Homologous
D015415:Biomarkers; D000681:Amylases